BIVI · BioVie Inc
United States · RS rating 11 · As of 2026-10-14
| Price | 1.16 USD |
|---|---|
| 1-day change | -3.3% |
| RS rating (overall / 1M / 3M / 12M) | 11 / 5 / 10 / 17 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 20 / 27 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +21.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +49.1% |
| Market cap (USD) | $10.8M |